Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons

Neurosci Biobehav Rev. 2023 Sep:152:105287. doi: 10.1016/j.neubiorev.2023.105287. Epub 2023 Jun 15.

Abstract

The noradrenergic locus coeruleus (LC) is among the first regions of the brain affected by pathology in both Alzheimer's disease (AD) and Parkinson's disease (PD), but the reasons for this selective vulnerability are not completely understood. Several features of LC neurons have been proposed as contributing factors to this dysfunction and degeneration, and this review will focus on the presence of neuromelanin (NM). NM is a dark pigment unique to catecholaminergic cells that is formed of norepinephrine (NE) and dopamine (DA) metabolites, heavy metals, protein aggregates, and oxidated lipids. We cover what is currently known about NM and the limitations of historical approaches, then discuss the new human tyrosinase (hTyr) model of NM production in rodent catecholamine cells in vivo that offers unique opportunities for studying its neurobiology, neurotoxicity, and potential of NM-based therapeutics for treating neurodegenerative disease.

Keywords: Alzheimer’s disease; Dopamine; Locus coeruleus; Neuromelanin; Norepinephrine; Parkinson’s disease; Tyrosinase.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Axons / metabolism
  • Catecholamines / metabolism
  • Humans
  • Locus Coeruleus* / metabolism
  • Melanins* / metabolism
  • Melanins* / toxicity
  • Monophenol Monooxygenase / metabolism
  • Neurodegenerative Diseases* / metabolism
  • Neurodegenerative Diseases* / pathology
  • Neurons* / metabolism

Substances

  • neuromelanin
  • Monophenol Monooxygenase
  • Catecholamines
  • Melanins